中证报中证网讯(记者宋维东)中国证券报记者12月12日从东软集团（600718）获悉，东软集团与沈阳药 科大学日前签署战略合作协议。双方将以数据价值化为核心，聚焦药物研发与医疗健康领域的创新融 合，开展全方位战略合作。此举进一步深化"医药研产用"协同与融合，为医药产业高质量发展赋能增 效。 双方合作，依托东软集团在医疗健康领域的积累与全链条布局，充分发挥沈阳药科大学在药学研究与人 才培养的深厚积淀，着重围绕构建智能化临床研究平台、研发药学辅助系统、推进AI+药物创新研究及 共建人才培养体系四大领域展开。双方将整合并规范临床数据与真实世界数据，打造"数据–科研–产业– 应用"闭环，实现从数据合规整合、研究降本提效到科研突破与成果转化的全链条医疗数据价值释放。 具体来看，面向医院和区域，共同打造智能化、一体化的临床研究平台，通过该平台提高在临床试验关 键环节的全流程高效协同，提升数据采集速度和准确性，确保数据合规，为患者用药安全提供保障。同 时，通过临床数据、真实世界数据的研究充分释放数据价值；围绕医院、基层医疗场景需求，联合研发 药学相关辅助系统，筑牢合理用药安全防线。 此外，合作开展AI+化学药、中药、生物药 ...

Core Viewpoint - Zhonghuan New Energy Holdings Group has launched its 16th winter warmth initiative, emphasizing its commitment to social responsibility and community support through charitable actions [1] Group 1: Corporate Social Responsibility - The initiative took place in Baiyangwa Village, Ningxia Hui Autonomous Region, where 105 households received cash donations and winter supplies [1] - The company has donated over 90 million yuan in total over the past 20 years, reflecting its belief that corporate growth should be accompanied by social contributions [1] Group 2: Future Commitment - Looking ahead, Zhonghuan New Energy aims to align with the "14th Five-Year Plan" goals, maintaining its mission of "serving the country through industry, giving back to society, and treating the public well" [1] - The company is dedicated to continuing its charitable efforts, contributing to the improvement of social welfare and the creation of a beautiful China [1]

在国务院国资委指导下，央企融资租赁联盟自2023年6月成立以来，先后在天津、西藏举办专题活动， 推动提升融资租赁行业落实国家战略、服务央企实体经济的能力水平。截至2025年三季度末，联盟推动 成员单位实现租赁业务合作900亿元，行业影响力和市场竞争力不断提升。 海南省副省长赵峰表示，海南正锚定党中央赋予的战略使命，全力推进全岛封关运作。融资租赁是贴近 实体经济的金融工具，也是驱动产业升级、培育新质生产力的重要金融引擎，与海南自贸港建设需求高 度契合。希望以此次活动为新起点，持续深化央地战略协同和产融创新合作，实现央企融资租赁联盟与 海南战略发展同频共振，在自贸港建设的宏伟蓝图中携手共进、共赢未来。 会上，相关央企融资租赁公司、三亚市投资促进局、海南省国有企业和金融机构等17家单位签署8项助 力海南自贸港建设的合作协议，央企融资租赁联盟发布《关于支持海南自贸港高质量发展的倡议书》， 央企融资租赁公司代表开展行业对话。 中证报中证网讯(记者刘丽靓)12月11日，中国国新联合海南省委金融办、海南省国资委、三亚市政府、 央企融资租赁联盟在海南三亚共同举办中央企业融资租赁助力海南自贸港建设大会暨央企融资租赁联盟 走进海 ...

Group 1 - The central economic work conference emphasized "expanding the supply of quality goods and services," aligning with the "14th Five-Year Plan" to stimulate consumer demand through supply-side measures [1] - In 2025, fixed asset investment in China decreased by 1.7% year-on-year from January to October, with expectations for stabilization in 2026 through increased central budget investments and activation of private investment [1] - The conference highlighted the establishment of an "international technology innovation center" and the development of a comprehensive plan for education and talent in technology, indicating a strategic shift from "investment in objects" to "investment in people" [1] Group 2 - New development opportunities are anticipated in sectors such as productive services, discretionary consumption, technology, and new materials [1]

会议指出，"我国经济长期向好的支撑条件和基本趋势没有改变"。刘元瑞认为，会议对当前经济形势的 判断，可以用"客观且积极"来概括。"客观"体现在对外部形势的清醒研判，"积极"体现在面对内外挑战 所彰显的必胜信心。 在他看来，继今年4月底政治局会议、12月初政治局会议后，本次会议再次提到了"统筹国内经济工作和 国际经贸斗争"，这延续了党的二十届四中全会的判断基调，体现了对外部形势研判的连贯性。 与去年会议相比，刘元瑞认为，今年会议同样提出了"经济发展中的老问题和新挑战"，也同样强调 了"长期向好的支撑条件和基本趋势没有变"。但不同之处在于，今年会议新增了"这些大多是发展中、 转型中的问题，经过努力是可以解决的"的判断，这和党的二十届四中全会的"保持必胜信心"相互印 证。信心不仅来自于制度优势，更来自于对于困难的本质的深刻理解，以及能否解决的精准判断。 会议提出，"推动经济实现质的有效提升和量的合理增长"。刘元瑞表示，随着我国经济从高速增长转向 高质量发展，经济增长更加注重质的有效提升。从此前《党的二十届四中全会〈建议〉学习辅导百问》 中的论述来看，未来十年只要能保持GDP年均增速不低于4.17%，就能够实现203 ...

Core Insights - The average stock private equity position in China has reached a new high for the year, currently at 82.98% as of December 5, marking a significant increase from 73.54% at the end of 2024, with a cumulative rise of 9.44 percentage points [1] - The trend of increasing positions has been particularly notable since August 2025, with an increase of 9.05 percentage points over four months [1] - Nearly 70% of stock private equity firms (68.80%) are now in a heavy or full position (over 80% allocation) [1] - Leading private equity firms are driving this increase, with billion-level private equity firms averaging a position of 89.02%, the highest among all size categories [1]

Core Viewpoint - Blue Sky Gas announced that its controlling shareholder, Blue Sky Group, has pledged 12.26 million shares to Beijing Tianyue Runyuan Trade Co., Ltd. for liquidity purposes, with significant implications for shareholding structure and financial health [1][2] Group 1: Share Pledge Details - Blue Sky Group pledged 3.0694 million shares starting from December 9, 2025, maturing on October 28, 2026, and 9.1939 million shares starting from December 10, 2025, maturing on October 11, 2026 [1] - After this pledge, Blue Sky Group has a total of 26.9 million shares pledged, representing 83.80% of its holdings and 37.57% of the total shares of Blue Sky Gas [1] - The actual controller, Li Xinhua, holds 46.76 million shares, with 44 million shares pledged, resulting in a pledge ratio of 94.10% [1] Group 2: Financial Health of Blue Sky Group - As of the announcement date, Blue Sky Group has total assets of 14.241 billion yuan and total liabilities of 9.051 billion yuan, leading to a debt-to-asset ratio of 63.55% [1] - The total bank loans amount to 5.484 billion yuan, with a bond balance of 150 million yuan and a bond repayment due within the next year also at 150 million yuan [1] - The current credit rating of Blue Sky Group is AA [1] Group 3: Impact on Company Operations - The share pledge by Blue Sky Group is not expected to have a significant impact on the company's operations, main business, financing credit, financing costs, or ongoing viability [2] - The pledge does not affect Blue Sky Group's status as the controlling shareholder or the company's governance structure [2] - Additionally, 30.9134 million shares held by Blue Sky Group have been judicially frozen by the Zhengzhou High-tech Industrial Development Zone People's Court [2]

Core Viewpoint - Kangzheng Pharmaceutical's new drug application for Y-3 has been officially accepted by the National Medical Products Administration, targeting acute ischemic stroke treatment and potentially preventing post-stroke depression and anxiety symptoms [1][2] Group 1: Product Development - Y-3 is the world's first multi-target neuroprotective agent aimed at PSD95-nNOS and MPO, showing promising efficacy in treating ischemic stroke [1] - The company has established a strong presence in the central nervous system field, with a product portfolio that includes the marketed innovative drug Vituco and the original brand drug Dailixin, along with the NDA-reviewed modified new drug ZUNVEYL [1] Group 2: Clinical Research and Impact - The burden of stroke-related disabilities has increased over the past thirty years, with post-stroke depression and anxiety affecting approximately 30% and 25% of patients, respectively [2] - Y-3 has reached its primary efficacy endpoint in Phase III clinical trials in China, demonstrating significant clinical benefits and good overall safety [2] - The main research results for Y-3 are planned to be presented at international academic conferences, with the overall study set to be published in international academic journals [2]

中证报中证网讯(龚梦泽熊永红)12月11日，零跑汽车在港交所发布的公告显示，公司股东、董事长兼首 席执行官朱江明及公司股东傅利泉近期于市场内合共购入2150600股本公司H股(本次增持)，平均价格为 每股约50.51港元，合共增持金额超1亿港元。 中国证券报记者注意到，本次增持后，朱江明、傅利泉及所属的公司单一最大股东集团合共持有公司 209100538股H股及128517839股内资股，占公司已发行总股数的23.75%。截至目前，零跑单一最大股东 集团累计增持金额已超9.5亿港币，创始人及核心股东持续增持彰显了对公司的发展信心。 公司业绩方面，今年11月，零跑全系交付创新高至70327辆，连续9个月稳居新势力月销冠军。今年三季 度，零跑汽车净利润持续为正，并呈现稳健盈利态势。 ...

爱建证券将国家与行业导向内化为数字化转型核心准则，从践行"金融为民"初心、恪守"守正创新"底 线、追求"专业质量"标杆三方面发力，彰显金融机构责任担当。 中证报中证网讯（王珞）近期，爱建证券"爱建先禾APP"凭借卓越的产品稳定性与用户体验，获Gtest 2025全球软件测试技术峰会"优秀软件产品质量"大奖；"大模型赋能财务数字化的应用实践"项目以技术 与业务的深度融合创新，摘得"券商数字化转型优秀案例奖"。这标志着爱建证券依托"技术研发强、业 务理解深、部门协同佳"资源禀赋，走出了一条政策契合度高、特色辨识度强的数字化发展路径。 未来，爱建证券表示将继续锚定数字金融方向，深化AI、大数据与业务融合，在C端优化用户体验，在 B端拓展赋能场景，以技术探索与精准落地，在证券行业数字化转型中领航，为客户创造更高价值，为 行业发展贡献力量。 爱建证券在C端服务优化与B端业务赋能上同步发力，构建"功能+场景+体验"三维服务体系，让"爱建先 禾APP"成为客户信赖的"智能理财管家"；以数字化工具破解内部效率瓶颈，推动"经验驱动"向"数据驱 动"转型，为多业务条线赋能，提升整体效能。 ...